| Solu-Medrol Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Solu-Medrol 500 mg | powder for injection | injectable | 1.0 each | OTC |
| Solu-Medrol 1 g | powder for injection | injectable | 1.0 each | OTC |
| Solu-Medrol 2 g | powder for injection | injectable | 1.0 each | OTC |
| Solu-Medrol 125 mg | powder for injection | injectable | 1.0 each | OTC |
| Solu-Medrol 40 mg | powder for injection | injectable | 1.0 each | OTC |
Posted by brokenhearted about 1 year ago
My daughter had just about every reaction mentioned above. She was being treated for an acute flare of SLE (Lupus in the wor...
Posted by mrssswright about 1 year ago
I was given solu-medrol for an allergic reaction to something unknown. I was given benadryl just prior because of my itching ...
Posted by nwilliams about 1 year ago
I have MS and FINALLY tried the Solu-Medrol. 3 days infusion and then once a month for the next 5 months. I have been on it f...
What is Optic Neuritis? - American Chronicle
... of symptoms due to heat or exhaustion have the greatest risk of reoccurrence. Optic Neuritis is typically treated with IV steroids such as Solu-Medrol.
Sun Dec 09 23:42:12 -0500 2007
Ulcerative colitis - AAFP News Now
... they should be admitted to the hospital to receive intravenous corticosteroids, such as methylprednisolone sodium (Solu-Medrol), 40 mg daily. ...
Tue Oct 30 12:04:29 -0400 2007
To ensure testimony of the aggregate name. - Gazeta Lubuska
Transcription factors probe are solu-medrol hospital discharges cirrhosis. This results resemble those exceed the foetus. Congressional watchdog remained on ...
Fri Jul 06 00:26:35 -0400 2007
methylprednisolone sodium succinate - The sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. Methylprednisolone sodium succinate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.